Takahiro Maeda

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Leukemia

Blood

Nature genetics

Bone marrow transplantation

Kyushu University School of Medicine

Nagoya University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kyushu University School of Medicine Mar 1o 2020

Japan

Professor :: Precision Medicine

Education History

Nagoya University Oct 1o 1998 - Mar 31o 2002

Japan

PHD :: Hematology/Oncology

Publications

Takahiro Maeda
CELMoD for ALL: an exciting prospect. Blood 142 (7) (2023)
Fumihiko Nakao, Kiyoko Setoguchi, Yuichiro Semba, Takuji Yamauchi, Jumpei Nogami, Kensuke Sasaki, Hiroshi Imanaga, Tatsuya Terasaki, Manaka Miyazaki, Shigeki Hirabayashi, Kohta Miyawaki, Yoshikane Kikushige, Takeshi Masuda, Koichi Akashi, Takahiro Maeda
Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance. Leukemia (2023)
Yosuke Komata, Akinori Kanai, Takahiro Maeda, Toshiya Inaba, Akihiko Yokoyama
MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins. Nature communications 14 (1) (2023)
Kensuke Sasaki, Takuji Yamauchi, Yuichiro Semba, Jumpei Nogami, Hiroshi Imanaga, Tatsuya Terasaki, Fumihiko Nakao, Koshi Akahane, Takeshi Inukai, Els Verhoeyen, Koichi Akashi, Takahiro Maeda
Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL. Blood (2021)
Kohta Miyawaki, Koji Kato, Takeshi Sugio, Kensuke Sasaki, Hiroaki Miyoshi, Yuichiro Semba, Yoshikane Kikushige, Yasuo Mori, Yuya Kunisaki, Hiromi Iwasaki, Toshihiro Miyamoto, Frank C Kuo, Jon C Aster, Koichi Ohshima, Takahiro Maeda, Koichi Akashi
A Germinal Center-Associated Microenvironmental Signature Reflects Malignant Phenotype and Outcome of DLBCL. Blood advances (2021)
Takuji Yamauchi, Kohta Miyawaki, Yuichiro Semba, Masatomo Takahashi, Yoshihiro Izumi, Jumpei Nogami, Fumihiko Nakao, Takeshi Sugio, Kensuke Sasaki, Luca Pinello, Daniel E Bauer, Takeshi Bamba, Koichi Akashi, Takahiro Maeda
Targeting leukemia-specific dependence on the de novo purine synthesis pathway. Leukemia (2021)
Tatsushi Kodama, Yu Kochi, Waka Nakai, Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi
Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple Myeloma. Molecular cancer therapeutics 18 (9) (2019)
Mariko Minami, Takumi Matsushima, Yasuo Mori, Daisuke Ishihara, Fumiaki Jinnnouchi, Katsuto Takenaka, Tomoko Henzan, Goichi Yoshimoto, Akihiko Numata, Koji Kato, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akashi
Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody. Bone marrow transplantation 54 (8) (2019)
Falak Sher, Mir Hossain, Davide Seruggia, Vivien A C Schoonenberg, Qiuming Yao, Paolo Cifani, Laura M K Dassama, Mitchel A Cole, Chunyan Ren, Divya S Vinjamur, Claudio Macias-Trevino, Kevin Luk, Connor McGuckin, Patrick G Schupp, Matthew C Canver, Ryo Kurita, Yukio Nakamura, Yuko Fujiwara, Scot A Wolfe, Luca Pinello, Takahiro Maeda, Alex Kentsis, Stuart H Orkin, Daniel E Bauer
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis. Nature genetics 51 (7) (2019)

Takahiro Maeda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takahiro Maeda